ValuEngine upgraded shares of Senomyx (NASDAQ:SNMX) from a hold rating to a buy rating in a research report released on Friday morning.

Shares of Senomyx stock traded down $0.01 during trading on Friday, hitting $1.48. The stock had a trading volume of 157,942 shares, compared to its average volume of 380,824. The firm has a market cap of $72.02 million, a price-to-earnings ratio of -49.33 and a beta of 1.50. Senomyx has a fifty-two week low of $0.80 and a fifty-two week high of $1.71.

Senomyx (NASDAQ:SNMX) last announced its quarterly earnings data on Thursday, August 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The business had revenue of $3.29 million during the quarter. Senomyx had a negative return on equity of 15.80% and a negative net margin of 9.11%.

In other news, major shareholder Senvest Management, Llc sold 2,689,504 shares of the company’s stock in a transaction on Monday, September 17th. The stock was sold at an average price of $1.48, for a total value of $3,980,465.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 13.00% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. raised its position in shares of Senomyx by 13.9% during the second quarter. BlackRock Inc. now owns 1,062,279 shares of the specialty chemicals company’s stock worth $1,275,000 after purchasing an additional 129,585 shares during the period. Renaissance Technologies LLC raised its position in shares of Senomyx by 14.4% during the second quarter. Renaissance Technologies LLC now owns 947,100 shares of the specialty chemicals company’s stock worth $1,137,000 after purchasing an additional 119,500 shares during the period. Kassirer Asset Management Corp acquired a new stake in shares of Senomyx during the third quarter worth $1,332,000. Finally, Quantum Capital Management raised its position in shares of Senomyx by 43.8% during the second quarter. Quantum Capital Management now owns 402,338 shares of the specialty chemicals company’s stock worth $483,000 after purchasing an additional 122,525 shares during the period. 30.71% of the stock is currently owned by institutional investors.

Senomyx Company Profile

Senomyx, Inc discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents.

Further Reading: What is the Ex-Dividend Date in Investing?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with MarketBeat.com's FREE daily email newsletter.